Esab [ESAB] vs CompoSecure [CMPO] Detailed Stock Comparison

Esab

CompoSecure
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Esab wins in 9 metrics, CompoSecure wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | Esab | CompoSecure | Better |
---|---|---|---|
P/E Ratio (TTM) | 25.72 | 13.73 | CompoSecure |
Price-to-Book Ratio | 3.45 | -19.59 | CompoSecure |
Debt-to-Equity Ratio | 55.25 | 0.00 | CompoSecure |
PEG Ratio | -1.35 | -0.09 | Esab |
EV/EBITDA | 15.45 | 38.33 | Esab |
Profit Margin (TTM) | 9.36% | -28.15% | Esab |
Operating Margin (TTM) | 15.44% | 17.95% | CompoSecure |
EBITDA Margin (TTM) | 15.44% | 17.95% | CompoSecure |
Return on Equity | 14.87% | 37.45% | CompoSecure |
Return on Assets (TTM) | 6.74% | 11.33% | CompoSecure |
Free Cash Flow (TTM) | $303.62M | $121.11M | Esab |
Dividend Yield | 0.27% | N/A | N/A |
1-Year Return | 13.97% | 76.06% | CompoSecure |
Price-to-Sales Ratio (TTM) | 2.61 | 7.79 | Esab |
Enterprise Value | $8.09B | $2.08B | Esab |
EV/Revenue Ratio | 2.95 | 7.77 | Esab |
Gross Profit Margin (TTM) | 37.18% | N/A | N/A |
Revenue per Share (TTM) | $45 | $3 | Esab |
Earnings per Share (Diluted) | $4.57 | $-2.01 | Esab |
Beta (Stock Volatility) | 1.20 | 1.00 | CompoSecure |
Esab vs CompoSecure Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Esab | 0.92% | 6.81% | 3.07% | -6.29% | 4.16% | -0.65% |
CompoSecure | -2.80% | -1.59% | 7.66% | 37.17% | 91.81% | 60.52% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Esab | 13.97% | 242.74% | 135.12% | 135.12% | 135.12% | 135.12% |
CompoSecure | 76.06% | 395.62% | 148.72% | 148.72% | 148.72% | 148.72% |
News Based Sentiment: Esab vs CompoSecure
Esab
News based Sentiment: MIXED
October brought conflicting signals for ESAB, with a 'Sell' rating from Barchart.com countered by a 'Buy' rating from TipRanks. Insider activity, including both grants and sales of stock units, adds to the complexity, creating a mixed investment narrative.
CompoSecure
News based Sentiment: MIXED
October was a pivotal month for CompoSecure, marked by the serious issue of Nasdaq delisting alongside positive analyst upgrades and a favorable industry outlook. This creates a mixed investment narrative with significant risk and potential reward, making it a crucial period for the company's future.
Performance & Financial Health Analysis: Esab vs CompoSecure
Metric | ESAB | CMPO |
---|---|---|
Market Information | ||
Market Cap | $7.17B | $2.09B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 519,170 | 768,890 |
90 Day Avg. Volume | 474,380 | 989,753 |
Last Close | $118.64 | $19.80 |
52 Week Range | $100.17 - $135.97 | $9.24 - $21.00 |
% from 52W High | -12.75% | -5.71% |
All-Time High | $135.97 (Nov 04, 2024) | $21.00 (Sep 29, 2025) |
% from All-Time High | -12.75% | -5.71% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.01% | -1.00% |
Quarterly Earnings Growth | -0.19% | -1.00% |
Financial Health | ||
Profit Margin (TTM) | 0.09% | -0.28% |
Operating Margin (TTM) | 0.15% | 0.18% |
Return on Equity (TTM) | 0.15% | 0.37% |
Debt to Equity (MRQ) | 55.25 | 0.00 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $34.10 | $-1.04 |
Cash per Share (MRQ) | $4.25 | $0.05 |
Operating Cash Flow (TTM) | $309.95M | $66.60M |
Levered Free Cash Flow (TTM) | $197.44M | $159.49M |
Dividends | ||
Last 12-Month Dividend Yield | 0.27% | N/A |
Last 12-Month Dividend | $0.32 | $0.00 |
Valuation & Enterprise Metrics Analysis: Esab vs CompoSecure
Metric | ESAB | CMPO |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 25.72 | 13.73 |
Forward P/E | 21.85 | 18.03 |
PEG Ratio | -1.35 | -0.09 |
Price to Sales (TTM) | 2.61 | 7.79 |
Price to Book (MRQ) | 3.45 | -19.59 |
Market Capitalization | ||
Market Capitalization | $7.17B | $2.09B |
Enterprise Value | $8.09B | $2.08B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.95 | 7.77 |
Enterprise to EBITDA | 15.45 | 38.33 |
Risk & Other Metrics | ||
Beta | 1.20 | 1.00 |
Book Value per Share (MRQ) | $34.10 | $-1.04 |
Financial Statements Comparison: Esab vs CompoSecure
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ESAB | CMPO |
---|---|---|
Revenue/Sales | $715.59M | $0 |
Cost of Goods Sold | $449.54M | $0 |
Gross Profit | $266.05M | $0 |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $110.48M | $-2.66M |
EBITDA | $129.84M | $-2.64M |
Pre-Tax Income | $88.10M | $-66.80M |
Income Tax | $18.28M | $-1.76M |
Net Income (Profit) | $68.10M | $-26.13M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ESAB | CMPO |
---|---|---|
Cash & Equivalents | $258.22M | $9.51M |
Total Current Assets | $1.34B | $10.83M |
Total Current Liabilities | $686.47M | $47.09M |
Long-Term Debt | $1.12B | $0 |
Total Shareholders Equity | $2.11B | $-87.31M |
Retained Earnings | $720.47M | $-293.59M |
Property, Plant & Equipment | $415.45M | $0 |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ESAB | CMPO |
---|---|---|
Operating Cash Flow | $41.08M | $9.71M |
Capital Expenditures | $-2.69M | $0 |
Free Cash Flow | $28.12M | $2.62M |
Debt Repayment | $-2.50M | $0 |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ESAB | CMPO |
---|---|---|
Shares Short | 1.13M | 2.92M |
Short Ratio | 2.68 | 2.52 |
Short % of Float | 0.03% | 0.06% |
Average Daily Volume (10 Day) | 519,170 | 768,890 |
Average Daily Volume (90 Day) | 474,380 | 989,753 |
Shares Outstanding | 60.52M | 100.46M |
Float Shares | 56.68M | 38.20M |
% Held by Insiders | 0.06% | 0.54% |
% Held by Institutions | 0.97% | 0.61% |
Dividend Analysis & Yield Comparison: Esab vs CompoSecure
Metric | ESAB | CMPO |
---|---|---|
Last 12-Month Dividend | $0.32 | $0.00 |
Last 12-Month Dividend Yield | 0.27% | N/A |
3-Year Avg Annual Dividend | $0.23 | $0.08 |
3-Year Avg Dividend Yield | 0.09% | 4.58% |
3-Year Total Dividends | $0.70 | $0.25 |
Ex-Dividend Date | Apr 04, 2025 | May 17, 2024 |